Citations

Citations to this article as recorded by  

• Association between underweight and risk of heart failure in diabetes patients
  Tae Kyung Yoo, Kyung‐Do Han, Eun‐Jung Rhee, Won‐Young Lee
  Journal of Cachexia, Sarcopenia and Muscle.2024; 15(2): 671.     CrossRef
• Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification
  Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
  Diabetes & Metabolism Journal.2024; 48(1): 83.     CrossRef
• To do one and to get more: Part I. Diabetes and bone
  Wen-Ling Lee, Peng-Hui Wang, Szu-Ting Yang, Chia-Hao Liu, Wen-Hsun Chang, Fa-Kung Lee
  Journal of the Chinese Medical Association.2022; 85(10): 965.     CrossRef

Citations

Citations to this article as recorded by  

• Relative and Absolute Risks of Adverse Events with Real-World Use of SGLT2 Inhibitors in CKD
  Ayodele Odutayo, Adeera Levin
  Clinical Journal of the American Society of Nephrology.2023; 18(5): 557.     CrossRef
• Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
  Dong-Lim Kim, Seung-Eun Lee, Nan Hee Kim
  Endocrinology and Metabolism.2023; 38(1): 43.     CrossRef
• Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis
  Eun Sil Koh, Gheun-Ho Kim, Sungjin Chung
  Endocrinology and Metabolism.2023; 38(4): 359.     CrossRef
• SGLT2 and DPP4 inhibitors improve Alzheimer’s disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model
  A Young Sim, Da Hyun Choi, Jong Youl Kim, Eun Ran Kim, A-ra Goh, Yong-ho Lee, Jong Eun Lee
  Biomedicine & Pharmacotherapy.2023; 168: 115755.     CrossRef
• Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with chronic kidney disease
  Emma S. Speedtsberg, Martin Tepel
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Management of CKD
  Nimrit Goraya, Jennifer D. Moran
  Nephrology Self-Assessment Program.2022; 21(2): 146.     CrossRef
• Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders − New perspectives for combination therapy
  Peter Kolkhof, Amer Joseph, Ulrich Kintscher
  Pharmacological Research.2021; 172: 105859.     CrossRef
• Sodium‐Glucose Cotransporter 2 Inhibitors, All‐Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta‐Analysis and Meta‐Regression
  Ayodele Odutayo, Bruno R. da Costa, Tiago V. Pereira, Vinay Garg, Samir Iskander, Fatimah Roble, Rahim Lalji, Cesar A. Hincapié, Aquila Akingbade, Myanca Rodrigues, Arnav Agarwal, Bishoy Lawendy, Pakeezah Saadat, Jacob A. Udell, Francesco Cosentino, Peter
  Journal of the American Heart Association.2021;[Epub]     CrossRef
• Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
  Luis D’Marco, María Jesús Puchades, Lorena Gandía, Claudia Forquet, Elena Giménez-Civera, Nayara Panizo, Javier Reque, Isabel Juan-García, Valmore Bermúdez, José Luis Gorriz
  touchREVIEWS in Endocrinology.2021; 17(2): 84.     CrossRef
• Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review
  Jorge I. Fonseca-Correa, Ricardo Correa-Rotter
  Frontiers in Medicine.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Association between age at diagnosis of type 2 diabetes and cardiovascular morbidity and mortality risks: A nationwide population-based study
  Da Hea Seo, Mina Kim, Young Ju Suh, Yongin Cho, Seong Hee Ahn, Seongbin Hong, So Hun Kim
  Diabetes Research and Clinical Practice.2024; 208: 111098.     CrossRef
• Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
  R. Pelluri, S. Kongara, V. R. Nagasubramanian, S. Mahadevan, J. Chimakurthy
  Journal of Endocrinological Investigation.2023; 46(5): 855.     CrossRef
• Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study
  Harmanjit Singh, Ekta Arora, Seerat Narula, Mandeep Singla, Armaan Otaal, Jatin Sharma
  Expert Review of Endocrinology & Metabolism.2023; 18(4): 347.     CrossRef
• Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes
  Yewon Na, Soo Wan Kim, Ie Byung Park, Soo Jung Choi, Seungyoon Nam, Jaehun Jung, Dae Ho Lee
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(11): 3022.     CrossRef

Citations

Citations to this article as recorded by  

• Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012
  Xiaowen Zhang, Yong Wang, Hongwei Wang, Xinlin Zhang
  The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e657.     CrossRef
• Adequacy of thyroid hormone replacement for people with hypothyroidism in real‐world settings: A systematic review and meta‐analysis of observational studies
  Agathoklis Efthymiadis, Matthew Henry, Dimitrios Spinos, Marianthi Bourlaki, Alexandros Tsikopoulos, Angeliki Bourazana, Anastasios Bastounis, Konstantinos Tsikopoulos
  Clinical Endocrinology.2024; 100(5): 488.     CrossRef
• Thyroid Disorders and Peripheral Arterial Disease
  Katica Bajuk Studen, Simona Gaberscek, Katja Zaletel, Ales Blinc, Miso Sabovic, Gerit-Holger Schernthaner, Panagiotis Anagnostis, Pier Luigi Antignani, Mojca Jensterle, Dimitri P Mikhailidis, Pavel Poredos
  Current Vascular Pharmacology.2024; 22(1): 36.     CrossRef
• Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation
  Pang-Shuo Huang, Jen-Fang Cheng, Jien-Jiun Chen, Yi-Chih Wang, Juey-Jen Hwang, Cho-Kai Wu, Chia-Ti Tsai
  The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): 92.     CrossRef
• Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)
  I. E. Chazova, N. M. Chikhladze, N. V. Blinova, Zh. E. Belaya, N. M. Danilov, E. M. Elfimova, A. Yu. Litvin, L. Ya. Rozhinskaya, N. Yu. Sviridenko, M. Yu. Shvetsov, V. A. Azizov, E. A. Grigorenko, N. P. Mit’kovskaja, I. I. Mustafaev, A. G. Polupanov, A. S
  Eurasian heart journal.2023; (1): 6.     CrossRef
• Sympathetic Activation Promotes Cardiomyocyte Apoptosis in a Rabbit Susceptibility Model of Hyperthyroidism-Induced Atrial Fibrillation via the p38 MAPK Signaling Pathway
  Jialin Zheng, Shijian Zhao, Qishi Yang, Yantao Wei, Jianmei Li, Tao Guo
  Critical Reviews in Eukaryotic Gene Expression.2023; 33(5): 17.     CrossRef
• Cardiovascular outcomes in subclinical thyroid disease: an update
  Matthew D. Ettleson
  Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(5): 218.     CrossRef
• Lower free triiodothyronine levels are associated with higher all-cause and cardiovascular mortality in people with diabetes-NHANES 2007–2012
  Chang Liu, Zhong Xin, Lin Hua
  Diabetes Research and Clinical Practice.2023; 202: 110811.     CrossRef
• Hyperthyroidism
  Sun Y. Lee, Elizabeth N. Pearce
  JAMA.2023; 330(15): 1472.     CrossRef
• Is Thyroid Dysfunction Associated with Unruptured Intracranial Aneurysms? A Population-Based, Nested Case–Control Study from Korea
  Hyeree Park, Sun Wook Cho, Sung Ho Lee, Kangmin Kim, Hyun-Seung Kang, Jeong Eun Kim, Aesun Shin, Won-Sang Cho
  Thyroid®.2023; 33(12): 1483.     CrossRef
• Risks of suboptimal and excessive thyroid hormone replacement across ages
  U. Feldt-Rasmussen, G. Effraimidis, S. Bliddal, M. Klose
  Journal of Endocrinological Investigation.2023; 47(5): 1083.     CrossRef
• Association of Mild Thyroid Dysfunction and Adverse Prognosis Among Chinese Patients With Acute ST Segment Elevation Myocardial Infarction
  Mei-Fang Li, Ze-Tao Wei, Shuai Li, Qi-Ming Feng, Jing-Bo Li
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The Cardiovascular Effects of Subclinical Hyperthyroidism following Percutaneous Coronary Intervention
  Ricardo Correa, Ricardo Villela
  Clinical Thyroidology.2022; 34(6): 240.     CrossRef
• Weight Gain and Body Composition Changes during the Transition of Thyroid Function in Patients with Graves’ Disease Undergoing Radioiodine Treatment
  Zhenqin Cai, Qiyu Chen, Yan Ling, Henrik Falhammar
  International Journal of Endocrinology.2022; 2022: 1.     CrossRef
• Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence
  Patrick Müller, Melvin Khee-Shing Leow, Johannes W. Dietrich
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Role of thyroid hormones-induced oxidative stress on cardiovascular physiology
  María Laura Barreiro Arcos
  Biochimica et Biophysica Acta (BBA) - General Subjects.2022; 1866(12): 130239.     CrossRef
• Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study
  Juqian Zhang, Arnaud Bisson, Grégoire Fauchier, Alexandre Bodin, Julien Herbert, Pierre Henri Ducluzeau, Gregory Y. H. Lip, Laurent Fauchier
  Journal of Clinical Medicine.2022; 11(5): 1342.     CrossRef
• Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis
  Yu-tian Cao, Kai-yu Zhang, Jing Sun, Yan Lou, Tian-su Lv, Xinyi Yang, Wen-hui Zhang, Jiang-yi Yu, Qi-biao Wu, Xi-qiao Zhou
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Subclinical Hyperthyroidism: A Review of the Clinical Literature
  Karen Tsai, Angela M. Leung
  Endocrine Practice.2021; 27(3): 254.     CrossRef
• Thyroid and heart, a clinically relevant relationship
  G. Corona, L. Croce, C. Sparano, L. Petrone, A. Sforza, M. Maggi, L. Chiovato, M. Rotondi
  Journal of Endocrinological Investigation.2021; 44(12): 2535.     CrossRef
• Antithyroid Drug Treatment in Graves’ Disease
  Jae Hoon Chung
  Endocrinology and Metabolism.2021; 36(3): 491.     CrossRef
• Cardiovascular Outcomes in Thyroid Cancer Patients Treated With Thyroidectomy: A Meta-Analysis
  Eun Kyung Lee, Hwa Young Ahn, Eu Jeong Ku, Won Sang Yoo, Young Ki Lee, Kee-Hyun Nam, Young Jun Chai, Shinje Moon, Yuh-Seog Jung
  The Journal of Clinical Endocrinology & Metabolism.2021;[Epub]     CrossRef

Branched-chain amino acids (BCAAs) are essential amino acids that are not synthesized in our body; thus, they need to be obtained from food. They have shown to provide many physiological and metabolic benefits such as stimulation of pancreatic insulin secretion, milk production, adipogenesis, and enhanced immune function, among others, mainly mediated by mammalian target of rapamycin (mTOR) signaling pathway. After identified as a reliable marker of obesity and type 2 diabetes in recent years, an increasing number of studies have surfaced implicating BCAAs in the pathophysiology of other diseases such as cancers, cardiovascular diseases, and even neurodegenerative disorders like Alzheimer's disease. Here we discuss the most recent progress and review studies highlighting both correlational and potentially causative role of BCAAs in the development of these disorders. Although we are just beginning to understand the intricate relationships between BCAAs and some of the most prevalent chronic diseases, current findings raise a possibility that they are linked by a similar putative mechanism.

Citations

Citations to this article as recorded by  

• First trimester metabolomics 1H-NMR study of the urinary profile predicts gestational diabetes mellitus development in obese women
  Cristina Piras, Isabella Neri, Roberta Pintus, Antonio Noto, Elisabetta Petrella, Francesca Monari, Angelica Dessì, Vassilios Fanos, Luigi Atzori, Fabio Facchinetti
  The Journal of Maternal-Fetal & Neonatal Medicine.2024; 35(25): 8275.     CrossRef
• Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
  Yaosi Liang, Christopher Pan, Tao Yin, Lu Wang, Xia Gao, Ergang Wang, Holly Quang, De Huang, Lianmei Tan, Kun Xiang, Yu Wang, Peter B. Alexander, Qi‐Jing Li, Tso‐Pang Yao, Zhao Zhang, Xiao‐Fan Wang
  Advanced Science.2024;[Epub]     CrossRef
• Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development
  Zi-Ran Kang, Shanshan Jiang, Ji-Xuan Han, Yaqi Gao, Yile Xie, Jinxian Chen, Qiang Liu, Jun Yu, Xin Zhao, Jie Hong, Haoyan Chen, Ying-Xuan Chen, Huimin Chen, Jing-Yuan Fang
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(2): 166941.     CrossRef
• Microbiome metabolite quantification methods enabling insights into human health and disease
  Jarrod Roach, Rohit Mital, Jacob J. Haffner, Nathan Colwell, Randy Coats, Horvey M. Palacios, Zongyuan Liu, Joseane L.P. Godinho, Monica Ness, Thilini Peramuna, Laura-Isobel McCall
  Methods.2024; 222: 81.     CrossRef
• Branched-chain amino acids promote occurrence and development of cardiovascular disease dependent on triglyceride metabolism via activation of the mTOR/SREBP-1/betatrophin pathway
  Jie Zhang, Ziyu Liu, Yaojun Ni, Yang Yu, Fei Guo, Yanwen Lu, Xiaoqing Wang, Hairong Hao, Shayan Li, Pan Wei, Weinan Yu, Wen Hu
  Molecular and Cellular Endocrinology.2024; 584: 112164.     CrossRef
• Heat stress reduces brown adipose tissue activity by exacerbating mitochondrial damage in type 2 diabetic mice
  Penghua Lai, Linlin Zhang, Yan Qiu, Jie Ren, Xue Sun, Ting Zhang, Liuyi Wang, Sijie Cheng, Sijia Liu, Hongli Zhuang, Daiwei Lu, Shaoliang Zhang, Huiqing Liang, Shaodong Chen
  Journal of Thermal Biology.2024; 119: 103799.     CrossRef
• Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition
  Marta Lopez-Yus, Carlos Hörndler, Sofia Borlan, Vanesa Bernal-Monterde, Jose M. Arbones-Mainar
  Cells.2024; 13(5): 380.     CrossRef
• Microbial production of branched chain amino acids: Advances and perspectives
  Yanan Hao, Xuewei Pan, Jiajia You, Guomin Li, Meijuan Xu, Zhiming Rao
  Bioresource Technology.2024; 397: 130502.     CrossRef
• Maintenance of the branched-chain amino acid transporter LAT1 counteracts myotube atrophy following chemotherapy
  Stephen Mora, Olasunkanmi A. J. Adegoke
  American Journal of Physiology-Cell Physiology.2024; 326(3): C866.     CrossRef
• Metabolomics of Mice with Type 2 Diabetes and Nonalcoholic Fatty Liver Treated by Acupuncture
  Yihui Guo, Liying Zhang, Mengyuan Li, Linan Lin, Fuyu Xue, Wanning Gao, Xiaoru Xu, Haipeng Huang, Abdelilah Arredouani
  International Journal of Endocrinology.2024; 2024: 1.     CrossRef
• Metabolic Signatures Elucidate the Effect of Body Mass Index on Type 2 Diabetes
  Qiuling Dong, Sidra Sidra, Christian Gieger, Rui Wang-Sattler, Wolfgang Rathmann, Cornelia Prehn, Jerzy Adamski, Wolfgang Koenig, Annette Peters, Harald Grallert, Sapna Sharma
  Metabolites.2023; 13(2): 227.     CrossRef
• The Preventive Effect of Exercise and Oral Branched-Chain Amino Acid Supplementation on Obesity-Induced Brain Changes in Ldlr−/−.Leiden Mice
  Klara J. Lohkamp, Anita M. van den Hoek, Gemma Solé-Guardia, Maria Lisovets, Talissa Alves Hoffmann, Konstantina Velanaki, Bram Geenen, Vivienne Verweij, Martine C. Morrison, Robert Kleemann, Maximilian Wiesmann, Amanda J. Kiliaan
  Nutrients.2023; 15(7): 1716.     CrossRef
• The Crosstalk between Gut Microbiota and White Adipose Tissue Mitochondria in Obesity
  Luca Colangeli, David Israel Escobar Marcillo, Valeria Simonelli, Egidio Iorio, Tommaso Rinaldi, Paolo Sbraccia, Paola Fortini, Valeria Guglielmi
  Nutrients.2023; 15(7): 1723.     CrossRef
• Prebiotic and Probiotic Modulation of the Microbiota–Gut–Brain Axis in Depression
  Daniel E. Radford-Smith, Daniel C. Anthony
  Nutrients.2023; 15(8): 1880.     CrossRef
• Machine learning model to predict obesity using gut metabolite and brain microstructure data
  Vadim Osadchiy, Roshan Bal, Emeran A. Mayer, Rama Kunapuli, Tien Dong, Priten Vora, Danny Petrasek, Cathy Liu, Jean Stains, Arpana Gupta
  Scientific Reports.2023;[Epub]     CrossRef
• Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer’s Disease
  Rui Liu, Lei Zhang, Hao You
  Journal of Alzheimer's Disease.2023; 93(3): 847.     CrossRef
• Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
  Rexiati Ruze, Tiantong Liu, Xi Zou, Jianlu Song, Yuan Chen, Ruiyuan Xu, Xinpeng Yin, Qiang Xu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment
  Tanner J. Wetzel, Sheila C. Erfan, Lucas D. Figueroa, Leighton M. Wheeler, Elitsa A. Ananieva
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Stachydrine, N‐acetylornithine and trimethylamine N‐oxide levels as candidate milk biomarkers of maternal consumption of an obesogenic diet during lactation
  Pedro Castillo, Ondrej Kuda, Jan Kopecky, Catalina Amadora Pomar, Andreu Palou, Mariona Palou, Catalina Picó
  BioFactors.2023; 49(5): 1022.     CrossRef
• Biofunctionalization of natural extracts, trends in biological activity and kinetic release
  Abraham Osiris Martínez-Olivo, Víctor Manuel Zamora-Gasga, Luis Medina-Torres, Alejandro Pérez-Larios, Sonia Guadalupe Sáyago-Ayerdi, Jorge Alberto Sánchez-Burgos
  Advances in Colloid and Interface Science.2023; 318: 102938.     CrossRef
• Muscle Traits, Sarcopenia, and Sarcopenic Obesity: A Vitamin D Mendelian Randomization Study
  Joshua P. Sutherland, Ang Zhou, Elina Hyppönen
  Nutrients.2023; 15(12): 2703.     CrossRef
• Bioactive Ingredients in Traditional Fermented Food Condiments: Emerging Products for Prevention and Treatment of Obesity and Type 2 Diabetes
  Alphonse Laya, Honoré Wangso, Iva Fernandes, Raphaël Djakba, Joana Oliveira, Eugenia Carvalho, Wen yi Kang
  Journal of Food Quality.2023; 2023: 1.     CrossRef
• Sex related differences in muscle health and metabolism in chronic obstructive pulmonary disease
  Mariëlle P.K.J. Engelen, Sarah K. Kirschner, Kimberly S. Coyle, David Argyelan, Gabriel Neal, Srinivasan Dasarathy, Nicolaas E.P. Deutz
  Clinical Nutrition.2023; 42(9): 1737.     CrossRef
• Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications
  Daniela Maria Tanase, Evelina Maria Gosav, Tina Botoc, Mariana Floria, Claudia Cristina Tarniceriu, Minela Aida Maranduca, Anca Haisan, Andrei Ionut Cucu, Ciprian Rezus, Claudia Florida Costea
  Journal of Clinical Medicine.2023; 12(18): 6053.     CrossRef
• Genetic and Lifestyle-Related Factors Influencing Serum Hyper-Propionylcarnitine Concentrations and Their Association with Metabolic Syndrome and Cardiovascular Disease Risk
  Yong-Hwa Lee, Sunmin Park
  International Journal of Molecular Sciences.2023; 24(21): 15810.     CrossRef
• Relationship between Components, Intestinal Microbiota, and Mechanism of Hypoglycemic Effect of the Saggy Ink Cap Medicinal Mushroom (Coprinus Comatus, Agaricomycetes): A Review
  Wei Wang, Min Sun, Jinyan Yu, Xumin Ma, Chunchao Han
  International Journal of Medicinal Mushrooms.2023; 25(12): 81.     CrossRef
• High-protein diet with excess leucine prevents inactivity-induced insulin resistance in women
  Alessandro Mangogna, Filippo Giorgio Di Girolamo, Nicola Fiotti, Pierandrea Vinci, Matteo Landolfo, Filippo Mearelli, Gianni Biolo
  Clinical Nutrition.2023; 42(12): 2578.     CrossRef
• Exploring the functional roles of small-molecule metabolites in disease research: Recent advancements in metabolomics
  Aolei Tan, Xiaoxiao Ma
  Chinese Chemical Letters.2023; : 109276.     CrossRef
• Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
  Aliya Lakhani, Da Hyun Kang, Yea Eun Kang, Junyoung O. Park
  Endocrinology and Metabolism.2023; 38(6): 619.     CrossRef
• Dietary intake of branched-chain amino acids in relation to general and abdominal obesity
  Farzaneh Asoudeh, Asma Salari-Moghaddam, Ammar Hassanzadeh Keshteli, Ahmad Esmaillzadeh, Peyman Adibi
  Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.2022; 27(4): 1303.     CrossRef
• Tea polyphenol – gut microbiota interactions: hints on improving the metabolic syndrome in a multi-element and multi-target manner
  Hui Ma, Yaozhong Hu, Bowei Zhang, Zeping Shao, Eugeni Roura, Shuo Wang
  Food Science and Human Wellness.2022; 11(1): 11.     CrossRef
• Exogenous isoleucine can confer browning resistance on fresh-cut potato by suppressing polyphenol oxidase activity and improving the antioxidant capacity
  Zan Meng, Tong Wang, Aman Ullah Malik, Qingguo Wang
  Postharvest Biology and Technology.2022; 184: 111772.     CrossRef
• Impact of thermal treatment and fermentation by lactic acid bacteria on sorghum metabolite changes, their antioxidant and antidiabetic activities
  Fred Kwame Ofosu, Fazle Elahi, Eric Banan-Mwine Daliri, Sang-Ik Han, Deog-Hwan Oh
  Food Bioscience.2022; 45: 101502.     CrossRef
• Infant intakes of human milk branched chain amino acids are negatively associated with infant growth and influenced by maternal body mass index
  Jessica L. Saben, Clark R. Sims, Lindsay Pack, Renny Lan, Elisabet Børsheim, Aline Andres
  Pediatric Obesity.2022;[Epub]     CrossRef
• Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations
  Laimdota Zizmare, Christina N. Boyle, Sabrina Buss, Sandrine Louis, Laura Kuebler, Ketki Mulay, Ralf Krüger, Lara Steinhauer, Isabelle Mack, Manuel Rodriguez Gomez, Kristina Herfert, Yvonne Ritze, Christoph Trautwein
  International Journal of Molecular Sciences.2022; 23(3): 1126.     CrossRef
• Omics Analyses of Intestinal Microbiota and Hypothalamus Clock Genes in Circadian Disturbance Model Mice Fed with Green Tea Polyphenols
  Yuting Zhang, Lu Cheng, Yanan Liu, Ruilin Zhang, Zufang Wu, Kejun Cheng, Xin Zhang
  Journal of Agricultural and Food Chemistry.2022; 70(6): 1890.     CrossRef
• Age, Sex, Body Mass Index, Diet and Menopause Related Metabolites in a Large Homogeneous Alpine Cohort
  Vinicius Verri Hernandes, Nikola Dordevic, Essi Marjatta Hantikainen, Baldur Bragi Sigurdsson, Sigurður Vidir Smárason, Vanessa Garcia-Larsen, Martin Gögele, Giulia Caprioli, Ilaria Bozzolan, Peter P. Pramstaller, Johannes Rainer
  Metabolites.2022; 12(3): 205.     CrossRef
• α-ketoisocaproic acid promotes ER stress through impairment of autophagy, thereby provoking lipid accumulation and insulin resistance in murine preadipocytes
  Tae Jun Park, Seung Yeon Park, Hyun Jung Lee, A.M. Abd El-Aty, Ji Hoon Jeong, Tae Woo Jung
  Biochemical and Biophysical Research Communications.2022; 603: 109.     CrossRef
• The associations of serum valine with mild cognitive impairment and Alzheimer’s disease
  Yong-lan Xiong, Joseph Therriault, Shu-jiang Ren, Xiao-jun Jing, Hua Zhang
  Aging Clinical and Experimental Research.2022; 34(8): 1807.     CrossRef
• The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
  Aikaterini Dimou, Vasilis Tsimihodimos, Eleni Bairaktari
  International Journal of Molecular Sciences.2022; 23(7): 4022.     CrossRef
• Obesity, exercise training, and BCAA supplementation: All that glitters (may not be) gold
  Stephen J. Carter, Emily B. Long, Cydne A. Perry
  Obesity.2022; 30(6): 1139.     CrossRef
• Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease
  Fei Guo, Rui Chen, Linghui Kong, Pan Wei, Ziyu Liu, Xiaoqing Wang, Hairong Hao, Yanwen Lu, Wen Hu
  Hepatology International.2022; 16(6): 1424.     CrossRef
• Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
  Xinyi Fang, Runyu Miao, Jiahua Wei, Haoran Wu, Jiaxing Tian
  Computational and Structural Biotechnology Journal.2022; 20: 5935.     CrossRef
• Targeted Metabolomics Revealed a Sex-Dependent Signature for Metabolic Syndrome in the Mexican Population
  Berenice Palacios-González, Guadalupe León-Reyes, Berenice Rivera-Paredez, Isabel Ibarra-González, Marcela Vela-Amieva, Yvonne N. Flores, Samuel Canizales-Quinteros, Jorge Salmerón, Rafael Velázquez-Cruz
  Nutrients.2022; 14(18): 3678.     CrossRef
• Case report: NAFLD and maple syrup urine disease: Is there an interplay between branched-chain amino acids and fructose consumption?
  Helena Moreira-Silva, Sandra Ferreira, Manuela Almeida, Isabel Gonçalves, Maria Augusta Cipriano, J. R. Vizcaíno, Ermelinda Santos-Silva, Esmeralda Gomes-Martins
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia
  Xi Xu, Jian Wang, Tong Tong, Wenwen Zhang, Jin Wang, Weiwei Ma, Shunqing Wang, Dunhua Zhou, Jun Wu, Linjia Jiang, Meng Zhao
  Haematologica.2022; 107(10): 2344.     CrossRef
• Effect of dietary protein content shift on aging in elderly rats by comprehensive quantitative score and metabolomics analysis
  Wenxuan Zheng, Ruiding Li, Yang Zhou, Fengcui Shi, Yao Song, Yanting Liao, Fan Zhou, Xiaohua Zheng, Jingwen Lv, Quanyang Li
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Caloric restriction improves glycaemic control without reducing plasma branched-chain amino acids or keto-acids in obese men
  M. H. Sayda, M. H. Abdul Aziz, N. Gharahdaghi, D. J. Wilkinson, P. L. Greenhaff, B. E. Phillips, K. Smith, I. Idris, P. J. Atherton
  Scientific Reports.2022;[Epub]     CrossRef
• Dietary Protein and Amino Acid Deficiency Inhibit Pancreatic Digestive Enzyme mRNA Translation by Multiple Mechanisms
  Maria Dolors Sans, Stephen J. Crozier, Nancy L. Vogel, Louis G. D’Alecy, John A. Williams
  Cellular and Molecular Gastroenterology and Hepatology.2021; 11(1): 99.     CrossRef
• Isoleucine increases muscle mass through promoting myogenesis and intramyocellular fat deposition
  Shuge Liu, Yunmei Sun, Rui Zhao, Yingqian Wang, Wanrong Zhang, Weijun Pang
  Food & Function.2021; 12(1): 144.     CrossRef
• Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography–mass spectrometry-based study
  Nazanin Moslehi, Parvin Mirmiran, Rezvan Marzbani, Hassan Rezadoost, Mehdi Mirzaie, Fereidoun Azizi, Fahimeh Ramezani Tehrani
  Human Reproduction.2021; 36(3): 721.     CrossRef
• Amino acid sensing pathway: A major check point in the pathogenesis of obesity and COVID‐19
  Aradhana Mariam Philips, Nooruddin Khan
  Obesity Reviews.2021;[Epub]     CrossRef
• The chemical mechanisms of the enzymes in the branched-chain amino acids biosynthetic pathway and their applications
  Yan-Fei Liang, Zi-Xian Long, Ya-Jian Zhang, Cai-Yun Luo, Le-Tian Yan, Wen-Yun Gao, Heng Li
  Biochimie.2021; 184: 72.     CrossRef
• Plasma Metabolomic Profiling in 1391 Subjects with Overweight and Obesity from the SPHERE Study
  Gianfranco Frigerio, Chiara Favero, Diego Savino, Rosa Mercadante, Benedetta Albetti, Laura Dioni, Luisella Vigna, Valentina Bollati, Angela Cecilia Pesatori, Silvia Fustinoni
  Metabolites.2021; 11(4): 194.     CrossRef
• Sarcopenic Obesity and Amino Acids: Concord Health and Ageing in Men Project
  David G Le Couteur, David J Handelsman, Fiona Stanaway, Louise M Waite, Fiona M Blyth, Vasi Naganathan, Robert G Cumming, Vasant Hirani, Rafael de Cabo
  The Journals of Gerontology: Series A.2021; 76(6): 1000.     CrossRef
• Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition
  Nathalie Kliemann, Vivian Viallon, Neil Murphy, Rebecca J. Beeken, Joseph A. Rothwell, Sabina Rinaldi, Nada Assi, Eline H. van Roekel, Julie A. Schmidt, Kristin Benjaminsen Borch, Claudia Agnoli, Ann H. Rosendahl, Hanna Sartor, José María Huerta, Anne Tjø
  BMC Medicine.2021;[Epub]     CrossRef
• Plasma Amino Acids and Residual Hypertriglyceridemia in Diabetic Patients Under Statins: Two Independent Cross-Sectional Hospital-Based Cohorts
  Shuang Wang, Yun-Feng Cao, Xiao-Yu Sun, Mo Hong, Zhong-Ze Fang, Hui-Huan Luo, Huan Sun, Ping Yang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Identification of Metabolic Phenotypes in Young Adults with Obesity by 1H NMR Metabolomics of Blood Serum
  Khin Thandar Htun, Jie Pan, Duanghathai Pasanta, Montree Tungjai, Chatchanok Udomtanakunchai, Sirirat Chancharunee, Siriprapa Kaewjaeng, Hong Joo Kim, Jakrapong Kaewkhao, Suchart Kothan
  Life.2021; 11(6): 574.     CrossRef
• A Metabolic Pattern in Healthy Subjects Given a Single Dose of Metformin: A Metabolomics Approach
  Lina A. Dahabiyeh, Muhammad Mujammami, Tawfiq Arafat, Hicham Benabdelkamel, Assim A. Alfadda, Anas M. Abdel Rahman
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Branched-chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-body Metabolism
  Gagandeep Mann, Stephen Mora, Glory Madu, Olasunkanmi A. J. Adegoke
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Identification of TBX15 as an adipose master trans regulator of abdominal obesity genes
  David Z. Pan, Zong Miao, Caroline Comenho, Sandhya Rajkumar, Amogha Koka, Seung Hyuk T. Lee, Marcus Alvarez, Dorota Kaminska, Arthur Ko, Janet S. Sinsheimer, Karen L. Mohlke, Nicholas Mancuso, Linda Liliana Muñoz-Hernandez, Miguel Herrera-Hernandez, Maria
  Genome Medicine.2021;[Epub]     CrossRef
• Antidiabetic Effect of Noodles Containing Fermented Lettuce Extracts
  Soon Yeon Jeong, Eunjin Kim, Ming Zhang, Yun-Seong Lee, Byeongjun Ji, Sun-Hee Lee, Yu Eun Cheong, Soon-Il Yun, Young-Soo Kim, Kyoung Heon Kim, Min Sun Kim, Hyun Soo Chun, Sooah Kim
  Metabolites.2021; 11(8): 520.     CrossRef
• Targeted and Untargeted Mass Spectrometry Reveals the Impact of High-Fat Diet on Peripheral Amino Acid Regulation in a Mouse Model of Alzheimer’s Disease
  Amelia L. Taylor, Don E. Davis, Simona G. Codreanu, Fiona E. Harrison, Stacy D. Sherrod, John A. McLean
  Journal of Proteome Research.2021; 20(9): 4405.     CrossRef
• The Association of 9 Amino Acids With Cardiovascular Events in Finnish Men in a 12-Year Follow-up Study
  Raimo Jauhiainen, Jagadish Vangipurapu, Annamaria Laakso, Teemu Kuulasmaa, Johanna Kuusisto, Markku Laakso
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(12): 3448.     CrossRef
• Serum Metabolite Profile Associated with Sex-Dependent Visceral Adiposity Index and Low Bone Mineral Density in a Mexican Population
  Berenice Palacios-González, Guadalupe León-Reyes, Berenice Rivera-Paredez, Isabel Ibarra-González, Marcela Vela-Amieva, Yvonne N. Flores, Samuel Canizales-Quinteros, Jorge Salmerón, Rafael Velázquez-Cruz
  Metabolites.2021; 11(9): 604.     CrossRef
• Branched chain amino acids—friend or foe in the control of energy substrate turnover and insulin sensitivity?
  Elżbieta Supruniuk, Ewa Żebrowska, Adrian Chabowski
  Critical Reviews in Food Science and Nutrition.2021; : 1.     CrossRef
• Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment
  Kate J. Russin, K. Sreekumaran Nair, Thomas J. Montine, Laura D. Baker, Suzanne Craft
  Journal of Alzheimer's Disease.2021; 84(2): 843.     CrossRef
• QSHY Granules Promote White Adipose Tissue Browning and Correct BCAAs Metabolic Disorder in NAFLD Mice
  Binbin Zhang, Mingzhu Ni, Xiaojing Li, Qiaohong Liu, Yiyang Hu, Yu Zhao
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4241.     CrossRef
• The Changes in Endogenous Metabolites in Hyperlipidemic Rats Treated with Herbal Mixture Containing Lemon, Apple Cider, Garlic, Ginger, and Honey
  Azliana Abu Bakar Sajak, Azrina Azlan, Faridah Abas, Hazilawati Hamzah
  Nutrients.2021; 13(10): 3573.     CrossRef
• Integration of Transcriptome and Metabolome Provides Unique Insights to Pathways Associated With Obese Breast Cancer Patients
  Mohammed A. Hassan, Kaltoom Al-Sakkaf, Mohammed Razeeth Shait Mohammed, Ashraf Dallol, Jaudah Al-Maghrabi, Alia Aldahlawi, Sawsan Ashoor, Mabrouka Maamra, Jiannis Ragoussis, Wei Wu, Mohammad Imran Khan, Abdulrahman L. Al-Malki, Hani Choudhry
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention
  Krasimira Aleksandrova, Caue Egea Rodrigues, Anna Floegel, Wolfgang Ahrens
  Current Obesity Reports.2020; 9(3): 219.     CrossRef
• Why Are Branched-Chain Amino Acids Increased in Starvation and Diabetes?
  Milan Holeček
  Nutrients.2020; 12(10): 3087.     CrossRef
• Differential gene signature in adipose tissue depots of growth hormone transgenic mice
  Silvana Duran‐Ortiz, Jonathan A. Young, Adam Jara, Elizabeth A. Jensen, Reetobrata Basu, Edward O. List, Yanrong Qian, John J. Kopchick, Darlene E. Berryman
  Journal of Neuroendocrinology.2020;[Epub]     CrossRef
• Prognostic Role of Serum Amino Acids in Head and Neck Cancer
  Gabriella Cadoni, Luca Giraldi, Carlo Chiarla, Jacopo Gervasoni, Silvia Persichilli, Aniello Primiano, Stefano Settimi, Jacopo Galli, Gaetano Paludetti, Dario Arzani, Stefania Boccia, Ivo Giovannini, Giovanni Almadori, Leigh A. Madden
  Disease Markers.2020; 2020: 1.     CrossRef
• Lipid changes in the metabolome of a single case study with maple syrup urine disease (MSUD) after five days of improved diet adherence of controlled branched-chain amino acids (BCAA)
  Teresa D. Douglas, L. Kristin Newby, Julie Eckstrand, Douglas Wixted, Rani H. Singh
  Molecular Genetics and Metabolism Reports.2020; 25: 100651.     CrossRef
• Branched chain amino acids, aging and age-related health
  David G. Le Couteur, Samantha M. Solon-Biet, Victoria C. Cogger, Rosilene Ribeiro, Rafael de Cabo, David Raubenheimer, Gregory J. Cooney, Stephen J. Simpson
  Ageing Research Reviews.2020; 64: 101198.     CrossRef
• Branched-chain ketoacid overload inhibits insulin action in the muscle
  Dipsikha Biswas, Khoi T. Dao, Angella Mercer, Andrew M. Cowie, Luke Duffley, Yassine El Hiani, Petra C. Kienesberger, Thomas Pulinilkunnil
  Journal of Biological Chemistry.2020; 295(46): 15597.     CrossRef

The prevalence of type 2 diabetes mellitus (T2DM), which is associated with cardiovascular morbidity and mortality, is increasing worldwide. Although there have been advances in diabetes treatments that reduce microvascular complications (nephropathy, neuropathy, retinopathy), many clinical studies have found that conventional oral hypoglycemic agents and glucose control alone failed to reduce cardiovascular disease. Thus, incretin-based therapies including glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT-2Is) represent a new area of research, and may serve as novel therapeutics for treating hyperglycemia and modifying other cardiovascular risk factors. Recently, it has been confirmed that several drugs in these classes, including canagliflozin, empagliflozin, semaglutide, and liraglutide, are safe and possess cardioprotective effects. We review the most recent cardiovascular outcome trials on GLP-1RAs and SGLT-2Is, and discuss their implications for treating patients with T2DM in terms of protective effects against cardiovascular disease.

Citations

Citations to this article as recorded by  

• Switch to gliflozins and biventricular function improvement in patients with chronic heart failure and diabetes mellitus
  Michele Correale, Pietro Mazzeo, Martino Fortunato, Matteo Paradiso, Andrea Furore, Angela I. Fanizzi, Lucia Tricarico, Giuseppe Pastore, Simona Alfieri, Natale D. Brunetti, Olga Lamacchia
  Clinical Physiology and Functional Imaging.2024; 44(1): 112.     CrossRef
• Association between underweight and risk of heart failure in diabetes patients
  Tae Kyung Yoo, Kyung‐Do Han, Eun‐Jung Rhee, Won‐Young Lee
  Journal of Cachexia, Sarcopenia and Muscle.2024; 15(2): 671.     CrossRef
• Paradigm Shift in Management of Hyperglycemia in Patients with Type 2 Diabetes: Glucocentric versus Organ Protection
  Jong Chul Won
  The Journal of Korean Diabetes.2023; 24(2): 59.     CrossRef
• Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies
  Braden Millar, Monica de Gaetano
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study
  Paolo Basile, Andrea Igoren Guaricci, Giuseppina Piazzolla, Sara Volpe, Alfredo Vozza, Marina Benedetto, Maria Cristina Carella, Daniela Santoro, Francesco Monitillo, Andrea Baggiano, Saima Mushtaq, Laura Fusini, Fabio Fazzari, Cinzia Forleo, Nunziata Rib
  Journal of Clinical Medicine.2023; 12(4): 1586.     CrossRef
• Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study
  Michele Correale, Elena‐Laura Antohi, Riccardo M. Inciardi, Pietro Mazzeo, Stefano Coiro, Shiro Ishihara, Renata Petroni, Francesco Monitillo, Marta Leone, Marco Triggiani, Chaudhry M.S. Sarwar, Hans‐Dirk Dungen, Khawaja M. Talha, Natale D. Brunetti, Jave
  ESC Heart Failure.2023; 10(3): 2066.     CrossRef
• Effects of Incretin-Based Treatment on the Diastolic (Dys)Function in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Prospective Study with 1-Year Follow-Up
  Elena-Daniela Grigorescu, Cristina-Mihaela Lăcătușu, Mariana Floria, Georgiana-Diana Cazac, Alina Onofriescu, Livia-Amira Sauciuc, Alexandr Ceasovschih, Ioana Crețu, Bogdan-Mircea Mihai, Laurențiu Șorodoc
  Diagnostics.2023; 13(17): 2817.     CrossRef
• Role of moesin in the effect of glucagon-like peptide-1 on advanced glycation end products-induced endothelial barrier dysfunction
  Yan Liu, Zhenzhen Chen, Lei Liu, Haitao Tang, Huaqing Zhu, Songtao Tang
  Cellular Signalling.2022; 90: 110193.     CrossRef
• Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes Therapy.2021; 12(1): 171.     CrossRef
• Effectiveness of liraglutide 3 mg for the treatment of obesity in a real-world setting without intensive lifestyle intervention
  Jung Ha Park, Ju Young Kim, Jong Han Choi, Hye Soon Park, Hyun-Young Shin, Jae Min Lee, Jin-Wook Kim, Hae-Jin Ko, Suk Chon, Bu Kyung Kim, Chul Sik Kim, Soo Lim
  International Journal of Obesity.2021; 45(4): 776.     CrossRef
• Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
  Shruti S Joshi, Trisha Singh, David E Newby, Jagdeep Singh
  Heart.2021; 107(13): 1032.     CrossRef
• Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis
  Da-Peng Zhang, Li Xu, Le-Feng Wang, Hong-Jiang Wang, Feng Jiang
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
  Kyung-Soo Kim, Byung-Wan Lee
  Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef
• Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus
  Kohei Kaku, Koichi Kisanuki, Mari Shibata, Takashi Oohira
  Drug Safety.2019; 42(11): 1311.     CrossRef

The proposal that diabetes plays a role in the development of heart failure is supported by the increased risk associated with this disease, even after correcting for all other known risk factors. However, the precise mechanisms contributing to the condition referred to as diabetic cardiomyopathy have remained elusive, as does defining the disease itself. Decades of study have defined numerous potential factors that each contribute to disease susceptibility, progression, and severity. Many recent detailed reviews have been published on mechanisms involving insulin resistance, dysregulation of microRNAs, and increased reactive oxygen species, as well as causes including both modifiable and non-modifiable risk factors. As such, the focus of the current review is to highlight aspects of each of these topics and to provide specific examples of recent advances in each area.

Citations

Citations to this article as recorded by  

• Upregulation of PCSK9, rho kinase and cardiac troponin by Eucalyptus globulus leaf extract improves fructose-streptozotocin-induced diabetic cardiac dysfunction in rats
  Afolabi C. Akinmoladun, Morenikejimi Bello, Emmanuel Oluwafemi Ibukun
  Archives of Physiology and Biochemistry.2023; 129(6): 1219.     CrossRef
• An Overview of Cardiotonic Medicinal Plants from the Perspective of Iranian Traditional Medicine
  Akram Alembagheri, Homa Hajimehdipoor, Rasool Choopani, Somayeh Esmaeili
  Jundishapur Journal of Natural Pharmaceutical Products.2023;[Epub]     CrossRef
• Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications
  Ana R. Nunes, Elisabete C. Costa, Gilberto Alves, Luís R. Silva
  Pharmaceuticals.2023; 16(5): 736.     CrossRef
• Cyp2e1 knockdown attenuates high glucose-induced apoptosis and oxidative stress of cardiomyocytes by activating PI3K/Akt signaling
  Jianying Wang, Han Yang, Chao Wang, Cuie Kan
  Acta Diabetologica.2023; 60(9): 1219.     CrossRef
• Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
  Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li
  World Journal of Hepatology.2023; 15(6): 786.     CrossRef
• Non-Invasive Assessment of the Intraventricular Pressure Using Novel Color M-Mode Echocardiography in Animal Studies: Current Status and Future Perspectives in Veterinary Medicine
  Ahmed S. Mandour, Ahmed Farag, Mahmoud A. Y. Helal, Gamal El-Masry, Salim Al-Rejaie, Ken Takahashi, Tomohiko Yoshida, Lina Hamabe, Ryou Tanaka
  Animals.2023; 13(15): 2452.     CrossRef
• Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
  Bongeka Cassandra Mkhize, Palesa Mosili, Phikelelani Sethu Ngubane, Ntethelelo Hopewell Sibiya, Andile Khathi
  Journal of Diabetes Investigation.2022; 13(5): 768.     CrossRef
• Knowledge domain and emerging trends in diabetic cardiomyopathy: A scientometric review based on CiteSpace analysis
  Shiyi Tao, Deshuang Yang, Lanxin Zhang, Lintong Yu, Zihan Wang, Lingling Li, Jin Zhang, Ruiqi Yao, Li Huang, Mingjing Shao
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors
  Joshua J Neumiller, Fredrick J Lienhard, Radica Z Alicic, Katherine R Tuttle
  European Endocrinology.2022; 18(2): 106.     CrossRef
• Protective effects of medicinal plant against diabetes induced cardiac disorder: A review
  Sadegh Shabab, Zahra Gholamnezhad, Maryam Mahmoudabady
  Journal of Ethnopharmacology.2021; 265: 113328.     CrossRef
• Toward a broader view of mechanisms of drug cardiotoxicity
  Polina Mamoshina, Blanca Rodriguez, Alfonso Bueno-Orovio
  Cell Reports Medicine.2021; 2(3): 100216.     CrossRef
• Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats
  Vikram Thakur, Narah Alcoreza, Monica Delgado, Binata Joddar, Munmun Chattopadhyay
  Biomolecules.2021; 11(4): 569.     CrossRef
• Cardioprotective Action of Glycyrrhizin on Diabetic Rats with Myocardial Remodeling
  Fuxu Chen, Jie Song, Enas Abdulhay
  Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
• Management of inflammation in cardiovascular diseases
  Sumanta Kumar Goswami, Prabhat Ranjan, Roshan Kumar Dutta, Suresh Kumar Verma
  Pharmacological Research.2021; 173: 105912.     CrossRef
• Diabetic Cardiomyopathy: Clinical and Metabolic Approach
  Dragan B. Djordjevic, Goran Koracevic, Aleksandar D. Djordjevic, Dragan B. Lovic
  Current Vascular Pharmacology.2021; 19(5): 487.     CrossRef
• Effect of Acute Chemotherapy on Glucose Levels in Rats
  Ahmad H. Alhowail, Gena S. Alfawzan, Maha A. Aldubayan, Lolwah S. Alsalam
  International Journal of Pharmacology.2020; 16(3): 276.     CrossRef
• Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity
  Sijing Liu, Yi Li, Xin Fan, Kai Li, Chunrong Xu, Liping Zhang, Mao Luo, Liqun Wang, Rong Li, Jianbo Wu
  Adipocyte.2020; 9(1): 170.     CrossRef
• Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
  Jeffrey I. Mechanick, Michael E. Farkouh, Jonathan D. Newman, W. Timothy Garvey
  Journal of the American College of Cardiology.2020; 75(5): 525.     CrossRef
• Associated Targets of the Antioxidant Cardioprotection of Ganoderma lucidum in Diabetic Cardiomyopathy by Using Open Targets Platform: A Systematic Review
  Fahmi Shaher, Hongbin Qiu, Shuqiu Wang, Yu Hu, Weiqun Wang, Yu Zhang, Yao Wei, Hisham AL-ward, Mahfoudh A. M. Abdulghani, Sattam Khulaif Alenezi, Salem Baldi, Shaobo Zhou
  BioMed Research International.2020; 2020: 1.     CrossRef
• Human trophoblast-derived exosomes attenuate doxorubicin-induced cardiac injury by regulating miR-200b and downstream Zeb1
  Jie Ni, Yihai Liu, Lina Kang, Lian Wang, Zhonglin Han, Kun Wang, Biao Xu, Rong Gu
  Journal of Nanobiotechnology.2020;[Epub]     CrossRef
• Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Glucagon-like Peptide-1 Receptor Agonists
  Emily J Cox, Radica Z Alicic, Joshua J Neumiller, Katherine R Tuttle
  US Endocrinology.2020; 16(2): 80.     CrossRef
• Hyperbaric Oxygen Therapy Dampens Inflammatory Cytokine Production and Does Not Worsen the Cardiac Function and Oxidative State of Diabetic Rats
  Rita Benkő, Zsuzsanna Miklós, Viktor Antal Ágoston, Katrine Ihonvien, Csaba Répás, Roland Csépányi-Kömi, Margit Kerék, Nóra Judit Béres, Eszter Mária Horváth
  Antioxidants.2019; 8(12): 607.     CrossRef
• Heart Failure in Type 2 Diabetes Mellitus
  Helena C. Kenny, E. Dale Abel
  Circulation Research.2019; 124(1): 121.     CrossRef
• SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
  Damilola D. Adingupu, Sven O. Göpel, Julia Grönros, Margareta Behrendt, Matus Sotak, Tasso Miliotis, Ulrika Dahlqvist, Li-Ming Gan, Ann-Cathrine Jönsson-Rylander
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus
  Paul J. Mills, Pam R. Taub, Ottar Lunde, Meredith A. Pung, Kathleen Wilson, Christopher Pruitt, Thomas Rutledge, Alan Maisel, Barry H. Greenberg
  Clinical Cardiology.2019; 42(6): 637.     CrossRef
• Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
  Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
  Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
• The Janus face of HMGB1 in heart disease: a necessary update
  Angela Raucci, Stefania Di Maggio, Francesco Scavello, Alessandro D’Ambrosio, Marco E. Bianchi, Maurizio C. Capogrossi
  Cellular and Molecular Life Sciences.2019; 76(2): 211.     CrossRef
• Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model
  Sabri Sudirman, Ching-Shu Lai, Yi-Ling Yan, Hung-I Yeh, Zwe-Ling Kong
  Scientific Reports.2019;[Epub]     CrossRef
• Microarray profiling analysis identifies the mechanism of miR‐200b‐3p/mRNA‐CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor‐γ signaling pathway
  Liqiong Xu, Wei Chen, Min Ma, Anfang Chen, Chengyue Tang, Chengwei Zhang, Lin Cai
  Journal of Cellular Biochemistry.2019; 120(4): 5193.     CrossRef
• Plasma Low-Density Lipoprotein Cholesterol Correlates With Heart Function in Individuals With Type 2 Diabetes Mellitus: A Cross-Sectional Study
  Po-Chung Cheng, Shang-Ren Hsu, Jung-Chi Li, Ching-Pei Chen, Szu-Chi Chien, Shih-Te Tu, Yun-Chung Cheng, Yu-Hsiu Liu, Jeng-Fu Kuo
  Frontiers in Endocrinology.2019;[Epub]     CrossRef
• Impact of diabetes mellitus on the contractile properties of the left and right atrial myofilaments†
  Constanze Bening, Khaled Alhussini, Elena-Aura Mazalu, Jonathan Yaqub, Khaled Hamouda, Dejan Radakovic, Christoph Schimmer, Grzegorz Hirnle, Rainer Leyh
  European Journal of Cardio-Thoracic Surgery.2018; 54(5): 826.     CrossRef
• LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling
  Lu Gao, Yuan Liu, Sen Guo, Lili Xiao, Leiming Wu, Zheng Wang, Cui Liang, Rui Yao, Yanzhou Zhang
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018; 1864(10): 3322.     CrossRef
• Gene expression profiles of rat MMECs with different glucose levels and fgl2 gene silencing
  Zhenzhong Zheng, Fan Zhang, Dengpeng Gao, Yujing Wu, Hao Wu
  Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
• Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
  Kwong-Man Ng, Yee-Man Lau, Vidhu Dhandhania, Zhu-Jun Cai, Yee-Ki Lee, Wing-Hon Lai, Hung-Fat Tse, Chung-Wah Siu
  Scientific Reports.2018;[Epub]     CrossRef
• Apelin‑13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high‑fat diet
  Meng Li, Huijuan Fang, Jian Hu
  Molecular Medicine Reports.2018;[Epub]     CrossRef
• Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis
  Kaviyarasi Renu, V.G. Abilash, P.B. Tirupathi Pichiah, Thabassum Akthar Syeda, Sankarganesh Arunachalam
  Asian Pacific Journal of Tropical Biomedicine.2017; 7(11): 1041.     CrossRef

Diabetes is a well-known risk factor of cardiovascular morbidity and mortality, and the beneficial effect of improved glycemic control on cardiovascular complications has been well established. However, the rosiglitazone experience aroused awareness of potential cardiovascular risk associated with diabetes drugs and prompted the U.S. Food and Drug Administration to issue new guidelines about cardiovascular risk. Through postmarketing cardiovascular safety trials, some drugs demonstrated cardiovascular benefits, while some antidiabetic drugs raised concern about a possible increased cardiovascular risk associated with drug use. With the development of new classes of drugs, treatment options became wider and the complexity of glycemic management in type 2 diabetes has increased. When choosing the appropriate treatment strategy for patients with type 2 diabetes at high cardiovascular risk, not only the glucose-lowering effects, but also overall benefits and risks for cardiovascular disease should be taken into consideration.

Citations

Citations to this article as recorded by  

• Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study
  Kyoung Jin Kim, Jimi Choi, Juneyoung Lee, Jae Hyun Bae, Jee Hyun An, Hee Young Kim, Hye Jin Yoo, Ji A. Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Sodium‐glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter‐organ crosstalk
  Jin Hee Kim, Minyoung Lee, Soo Hyun Kim, So Ra Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Jin Won Cho, Yong‐ho Lee
  Diabetes, Obesity and Metabolism.2019; 21(4): 801.     CrossRef
• Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
  Cheng-Wei Chan, Chu-Leng Yu, Jiunn-Cherng Lin, Yu-Cheng Hsieh, Che-Chen Lin, Chen-Ying Hung, Cheng-Hung Li, Ying-Chieh Liao, Chu-Pin Lo, Jin-Long Huang, Ching-Heng Lin, Tsu-Juey Wu
  Cardiovascular Diabetology.2018;[Epub]     CrossRef
• Normoglucemiantes orales y riesgo cardiovascular
  Guillermo Guzmán, Juan Esteban Gómez, Leidy Johanna Plaza, María Claudia Sánchez
  Revista Colombiana de Cardiología.2018; 25(5): 333.     CrossRef
• Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study
  N.H. Kim, J. Choi, N.H. Kim, K.M. Choi, S.H. Baik, J. Lee, S.G. Kim
  Diabetes & Metabolism.2018; 44(4): 361.     CrossRef
• Obesity and Type 2 Diabetes in Our Youth: A Recipe for Cardiovascular Disease
  Angela Kaye Wooton, Lynne M. Melchior
  The Journal for Nurse Practitioners.2017; 13(3): 222.     CrossRef
• Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes
  Ilaria Campesi, Flavia Franconi, Giuseppe Seghieri, Marco Meloni
  Pharmacological Research.2017; 119: 195.     CrossRef
• The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis
  Mona P. Nasrallah, Charbel Abi Khalil, Marwan M. Refaat
  BioMed Research International.2017; 2017: 1.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef

The leading cause of morbidity and mortality in patients with acromegaly is cardiovascular complications. Myocardial exposure to excessive growth hormone can cause ventricular hypertrophy, hypertension, arrhythmia, and diastolic dysfunction. However, congestive heart failure as a result of systolic dysfunction is observed only rarely in patients with acromegaly. Most cases of acromegaly exhibit high levels of serum insulin-like growth factor-1 (IGF-1). Acromegaly with normal IGF-1 levels is rare and difficult to diagnose. Here, we report a rare case of an acromegalic patient whose first clinical manifestation was severe congestive heart failure, despite normal IGF-1 levels. We diagnosed acromegaly using a glucose-loading growth hormone suppression test. Cardiac function and myocardial hypertrophy improved 6 months after transsphenoidal resection of a pituitary adenoma.

Citations

Citations to this article as recorded by  

• Risk of Neurodegenerative Diseases in Patients With Acromegaly
  Sangmo Hong, Kyungdo Han, Kyung-Soo Kim, Cheol-Young Park
  Neurology.2022;[Epub]     CrossRef
• Levels of Serum IGF-1, HCY, and Plasma BNP in Patients with Chronic Congestive Heart Failure and Their Relationship with Cardiac Function and Short-Term Prognosis
  Zhengyi Hu, Leifang Mao, Ling Wang, Weiguo Li
  Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
• Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly
  Shigemitsu Yasuda, Ikuo Inoue, Akira Shimada
  Internal Medicine.2021; 60(15): 2451.     CrossRef
• Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
  Hye Suk Kang, Ho-Chan Cho, Jae-Ho Lee, Goo Taeg Oh, Seung-Hoi Koo, Byung-Hyun Park, In-Kyu Lee, Hueng-Sik Choi, Dae-Kyu Song, Seung-Soon Im
  Scientific Reports.2016;[Epub]     CrossRef